Cargando…
Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate
Non-coding mutations may drive cancer development. Statistical detection of non-coding driver regions is challenged by a varying mutation rate and uncertainty of functional impact. Here, we develop a statistically founded non-coding driver-detection method, ncdDetect, which includes sample-specific...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440169/ https://www.ncbi.nlm.nih.gov/pubmed/28362259 http://dx.doi.org/10.7554/eLife.21778 |
_version_ | 1783238027698503680 |
---|---|
author | Juul, Malene Bertl, Johanna Guo, Qianyun Nielsen, Morten Muhlig Świtnicki, Michał Hornshøj, Henrik Madsen, Tobias Hobolth, Asger Pedersen, Jakob Skou |
author_facet | Juul, Malene Bertl, Johanna Guo, Qianyun Nielsen, Morten Muhlig Świtnicki, Michał Hornshøj, Henrik Madsen, Tobias Hobolth, Asger Pedersen, Jakob Skou |
author_sort | Juul, Malene |
collection | PubMed |
description | Non-coding mutations may drive cancer development. Statistical detection of non-coding driver regions is challenged by a varying mutation rate and uncertainty of functional impact. Here, we develop a statistically founded non-coding driver-detection method, ncdDetect, which includes sample-specific mutational signatures, long-range mutation rate variation, and position-specific impact measures. Using ncdDetect, we screened non-coding regulatory regions of protein-coding genes across a pan-cancer set of whole-genomes (n = 505), which top-ranked known drivers and identified new candidates. For individual candidates, presence of non-coding mutations associates with altered expression or decreased patient survival across an independent pan-cancer sample set (n = 5454). This includes an antigen-presenting gene (CD1A), where 5’UTR mutations correlate significantly with decreased survival in melanoma. Additionally, mutations in a base-excision-repair gene (SMUG1) correlate with a C-to-T mutational-signature. Overall, we find that a rich model of mutational heterogeneity facilitates non-coding driver identification and integrative analysis points to candidates of potential clinical relevance. DOI: http://dx.doi.org/10.7554/eLife.21778.001 |
format | Online Article Text |
id | pubmed-5440169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-54401692017-05-24 Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate Juul, Malene Bertl, Johanna Guo, Qianyun Nielsen, Morten Muhlig Świtnicki, Michał Hornshøj, Henrik Madsen, Tobias Hobolth, Asger Pedersen, Jakob Skou eLife Cancer Biology Non-coding mutations may drive cancer development. Statistical detection of non-coding driver regions is challenged by a varying mutation rate and uncertainty of functional impact. Here, we develop a statistically founded non-coding driver-detection method, ncdDetect, which includes sample-specific mutational signatures, long-range mutation rate variation, and position-specific impact measures. Using ncdDetect, we screened non-coding regulatory regions of protein-coding genes across a pan-cancer set of whole-genomes (n = 505), which top-ranked known drivers and identified new candidates. For individual candidates, presence of non-coding mutations associates with altered expression or decreased patient survival across an independent pan-cancer sample set (n = 5454). This includes an antigen-presenting gene (CD1A), where 5’UTR mutations correlate significantly with decreased survival in melanoma. Additionally, mutations in a base-excision-repair gene (SMUG1) correlate with a C-to-T mutational-signature. Overall, we find that a rich model of mutational heterogeneity facilitates non-coding driver identification and integrative analysis points to candidates of potential clinical relevance. DOI: http://dx.doi.org/10.7554/eLife.21778.001 eLife Sciences Publications, Ltd 2017-03-31 /pmc/articles/PMC5440169/ /pubmed/28362259 http://dx.doi.org/10.7554/eLife.21778 Text en © 2017, Juul et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cancer Biology Juul, Malene Bertl, Johanna Guo, Qianyun Nielsen, Morten Muhlig Świtnicki, Michał Hornshøj, Henrik Madsen, Tobias Hobolth, Asger Pedersen, Jakob Skou Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate |
title | Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate |
title_full | Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate |
title_fullStr | Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate |
title_full_unstemmed | Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate |
title_short | Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate |
title_sort | non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate |
topic | Cancer Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440169/ https://www.ncbi.nlm.nih.gov/pubmed/28362259 http://dx.doi.org/10.7554/eLife.21778 |
work_keys_str_mv | AT juulmalene noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate AT bertljohanna noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate AT guoqianyun noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate AT nielsenmortenmuhlig noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate AT switnickimichał noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate AT hornshøjhenrik noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate AT madsentobias noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate AT hobolthasger noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate AT pedersenjakobskou noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate |